Pharmabiz16h
Govt issues draft notification to extend deadline for implementation of revised Schedule M for SME units
Govt issues draft notification to extend deadline for implementation of revised Schedule M for SME units: Our Bureau, New Delhi Saturday, January 4, 2025, 20:30 Hrs [IST] In relie ...
Pharmabiz20h
Hanx Biopharma begins patient dosing in Australia for phase 1 trial of HX044 to treat advanced solid tumours
Hanx Biopharma begins patient dosing in Australia for phase 1 trial of HX044 to treat advanced solid tumours: Wuhan, China Saturday, January 4, 2025, 16:00 Hrs [IST] Hanx Biopharm ...
Pharmabiz19h
Nona Biosciences updates on its collaborator DualityBio’s ADC collaboration with BeiGene
Nona Biosciences updates on its collaborator DualityBio’s ADC collaboration with BeiGene: Cambridge, Massachusetts Saturday, January 4, 2025, 17:00 Hrs [IST] Nona Biosciences, a ...
Pharmabiz23h
NIH-funded study shows aging may change some brain cells more than others
NIH-funded study shows aging may change some brain cells more than others: Bethesda, Maryland Saturday, January 4, 2025, 13:00 Hrs [IST] Based on new brain mapping research funded ...
Pharmabiz22h
China NMPA approves Innovent Biologics’ Dovbleron to treat ROS1-positive non-small cell lung cancer
China NMPA approves Innovent Biologics’ Dovbleron to treat ROS1-positive non-small cell lung cancer: San Francisco Saturday, January 4, 2025, 14:00 Hrs [IST] Innovent Biologics, ...
Pharmabiz21h
Capricor Therapeutics seeks US FDA approval for deramiocel for the treatment of Duchenne muscular dystrophy
Capricor Therapeutics seeks US FDA approval for deramiocel for the treatment of Duchenne muscular dystrophy: San Diego Saturday, January 4, 2025, 15:00 Hrs [IST] Capricor Therapeu ...